Dual-mechanism based CTLs infiltration enhancement initiated by Nano-sapper potentiates immunotherapy against immune-excluded tumors

The exclusion of cytotoxic T cells remains an important barrier to the efficacy of immunotherapies. Here the authors demonstrate that the combination anti-fibrosis agents and immune-enhanced cytokines can enhance T cell infiltration in a mouse model of pancreatic cancer.

Guardado en:
Detalles Bibliográficos
Autores principales: Yukun Huang, Yu Chen, Songlei Zhou, Liang Chen, Jiahao Wang, Yuanyuan Pei, Minjun Xu, Jingxian Feng, Tianze Jiang, Kaifan Liang, Shanshan Liu, Qingxiang Song, Gan Jiang, Xiao Gu, Qian Zhang, Xiaoling Gao, Jun Chen
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2020
Materias:
Q
Acceso en línea:https://doaj.org/article/158cb6f07ed24ee38767bf2374a587c5
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:158cb6f07ed24ee38767bf2374a587c5
record_format dspace
spelling oai:doaj.org-article:158cb6f07ed24ee38767bf2374a587c52021-12-02T14:42:15ZDual-mechanism based CTLs infiltration enhancement initiated by Nano-sapper potentiates immunotherapy against immune-excluded tumors10.1038/s41467-020-14425-72041-1723https://doaj.org/article/158cb6f07ed24ee38767bf2374a587c52020-01-01T00:00:00Zhttps://doi.org/10.1038/s41467-020-14425-7https://doaj.org/toc/2041-1723The exclusion of cytotoxic T cells remains an important barrier to the efficacy of immunotherapies. Here the authors demonstrate that the combination anti-fibrosis agents and immune-enhanced cytokines can enhance T cell infiltration in a mouse model of pancreatic cancer.Yukun HuangYu ChenSonglei ZhouLiang ChenJiahao WangYuanyuan PeiMinjun XuJingxian FengTianze JiangKaifan LiangShanshan LiuQingxiang SongGan JiangXiao GuQian ZhangXiaoling GaoJun ChenNature PortfolioarticleScienceQENNature Communications, Vol 11, Iss 1, Pp 1-15 (2020)
institution DOAJ
collection DOAJ
language EN
topic Science
Q
spellingShingle Science
Q
Yukun Huang
Yu Chen
Songlei Zhou
Liang Chen
Jiahao Wang
Yuanyuan Pei
Minjun Xu
Jingxian Feng
Tianze Jiang
Kaifan Liang
Shanshan Liu
Qingxiang Song
Gan Jiang
Xiao Gu
Qian Zhang
Xiaoling Gao
Jun Chen
Dual-mechanism based CTLs infiltration enhancement initiated by Nano-sapper potentiates immunotherapy against immune-excluded tumors
description The exclusion of cytotoxic T cells remains an important barrier to the efficacy of immunotherapies. Here the authors demonstrate that the combination anti-fibrosis agents and immune-enhanced cytokines can enhance T cell infiltration in a mouse model of pancreatic cancer.
format article
author Yukun Huang
Yu Chen
Songlei Zhou
Liang Chen
Jiahao Wang
Yuanyuan Pei
Minjun Xu
Jingxian Feng
Tianze Jiang
Kaifan Liang
Shanshan Liu
Qingxiang Song
Gan Jiang
Xiao Gu
Qian Zhang
Xiaoling Gao
Jun Chen
author_facet Yukun Huang
Yu Chen
Songlei Zhou
Liang Chen
Jiahao Wang
Yuanyuan Pei
Minjun Xu
Jingxian Feng
Tianze Jiang
Kaifan Liang
Shanshan Liu
Qingxiang Song
Gan Jiang
Xiao Gu
Qian Zhang
Xiaoling Gao
Jun Chen
author_sort Yukun Huang
title Dual-mechanism based CTLs infiltration enhancement initiated by Nano-sapper potentiates immunotherapy against immune-excluded tumors
title_short Dual-mechanism based CTLs infiltration enhancement initiated by Nano-sapper potentiates immunotherapy against immune-excluded tumors
title_full Dual-mechanism based CTLs infiltration enhancement initiated by Nano-sapper potentiates immunotherapy against immune-excluded tumors
title_fullStr Dual-mechanism based CTLs infiltration enhancement initiated by Nano-sapper potentiates immunotherapy against immune-excluded tumors
title_full_unstemmed Dual-mechanism based CTLs infiltration enhancement initiated by Nano-sapper potentiates immunotherapy against immune-excluded tumors
title_sort dual-mechanism based ctls infiltration enhancement initiated by nano-sapper potentiates immunotherapy against immune-excluded tumors
publisher Nature Portfolio
publishDate 2020
url https://doaj.org/article/158cb6f07ed24ee38767bf2374a587c5
work_keys_str_mv AT yukunhuang dualmechanismbasedctlsinfiltrationenhancementinitiatedbynanosapperpotentiatesimmunotherapyagainstimmuneexcludedtumors
AT yuchen dualmechanismbasedctlsinfiltrationenhancementinitiatedbynanosapperpotentiatesimmunotherapyagainstimmuneexcludedtumors
AT songleizhou dualmechanismbasedctlsinfiltrationenhancementinitiatedbynanosapperpotentiatesimmunotherapyagainstimmuneexcludedtumors
AT liangchen dualmechanismbasedctlsinfiltrationenhancementinitiatedbynanosapperpotentiatesimmunotherapyagainstimmuneexcludedtumors
AT jiahaowang dualmechanismbasedctlsinfiltrationenhancementinitiatedbynanosapperpotentiatesimmunotherapyagainstimmuneexcludedtumors
AT yuanyuanpei dualmechanismbasedctlsinfiltrationenhancementinitiatedbynanosapperpotentiatesimmunotherapyagainstimmuneexcludedtumors
AT minjunxu dualmechanismbasedctlsinfiltrationenhancementinitiatedbynanosapperpotentiatesimmunotherapyagainstimmuneexcludedtumors
AT jingxianfeng dualmechanismbasedctlsinfiltrationenhancementinitiatedbynanosapperpotentiatesimmunotherapyagainstimmuneexcludedtumors
AT tianzejiang dualmechanismbasedctlsinfiltrationenhancementinitiatedbynanosapperpotentiatesimmunotherapyagainstimmuneexcludedtumors
AT kaifanliang dualmechanismbasedctlsinfiltrationenhancementinitiatedbynanosapperpotentiatesimmunotherapyagainstimmuneexcludedtumors
AT shanshanliu dualmechanismbasedctlsinfiltrationenhancementinitiatedbynanosapperpotentiatesimmunotherapyagainstimmuneexcludedtumors
AT qingxiangsong dualmechanismbasedctlsinfiltrationenhancementinitiatedbynanosapperpotentiatesimmunotherapyagainstimmuneexcludedtumors
AT ganjiang dualmechanismbasedctlsinfiltrationenhancementinitiatedbynanosapperpotentiatesimmunotherapyagainstimmuneexcludedtumors
AT xiaogu dualmechanismbasedctlsinfiltrationenhancementinitiatedbynanosapperpotentiatesimmunotherapyagainstimmuneexcludedtumors
AT qianzhang dualmechanismbasedctlsinfiltrationenhancementinitiatedbynanosapperpotentiatesimmunotherapyagainstimmuneexcludedtumors
AT xiaolinggao dualmechanismbasedctlsinfiltrationenhancementinitiatedbynanosapperpotentiatesimmunotherapyagainstimmuneexcludedtumors
AT junchen dualmechanismbasedctlsinfiltrationenhancementinitiatedbynanosapperpotentiatesimmunotherapyagainstimmuneexcludedtumors
_version_ 1718389736465235968